Reversal of β-amyloid induced microglial toxicity in vitro by activation of Fpr2/3
Edward S. Wickstead, Husnain A. Karim, Roberta E. Manuel, C.S. Biggs, Stephen J. Getting, Simon McArthur
This study shows that activating Fpr2 with QC1 reverses β-amyloid-induced microglial toxicity in vitro by reducing ROS production and metabolic shifts.
Oxidative Medicine and Cellular Longevity · Jun 15, 2020Peer-reviewedNeuroscience